Person-Centred Care in Practice: Perspectives from A Short-Course Regimen for Multi-Drug Resistant Tuberculosis in Karakalpakstan, Uzbekistan

Abstract

Introduction: Person-centred care, an internationally recognised priority, describes the involvement of people in their care and treatment decisions and the consideration of their needs and priorities within service delivery. Clarity is required regarding the feasibility of its implementation within different contexts. The standard multi-drug resistant tuberculosis (MDR-TB) treatment regimen is lengthy, toxic and insufficiently effective. 2019 World Health Organisation guidelines include a shorter (9-11-month) regimen and recommend that people with MDR-TB be involved in the choice of treatment option. We examine the perspectives and experiences of people with MDR-TB and health-care workers (HCW) on treatment choice in an MDR-TB programme in Karakalpakstan, Uzbekistan, run by Médecins Sans Frontières and the Ministry of Health. Methods: A qualitative study comprising 48 interviews with 24 people with MDR-TB and 20 HCW was conducted in June-July 2019. Participants were recruited purposively to include a range of treatment-taking experiences and professional positions. Interview data were analysed thematically using coding to identify emerging patterns, concepts, and categories relating to person-centred care, with Nvivo12. Results: People with MDR-TB were unfamiliar with shared decision-making and felt uncomfortable taking responsibility for their treatment choice. HCW were viewed as having greater knowledge and expertise, and patients trusted HCW to act in their best interests, deferring the choice of appropriate treatment course to them. HCW had concerns about involving people in treatment choices, preferring that doctors made decisions. People with MDR-TB wanted to be involved in discussions about their treatment, and have their preference sought, and were comfortable choosing whether treatment was ambulatory or hospital-based. Participants felt it important that people with MDR-TB had knowledge and understanding about their treatment and disease, to foster their sense of preparedness and ownership for treatment. Involving people in their care was said to motivate sustained treatment-taking, which some felt directly observed treatment (DOT) could undermine. Conclusions: There is a preference for doctors choosing the treatment regimen, linked to shared decision-making unfamiliarity and practitioner-patient knowledge imbalance. Involving people in their care, through discussions, information, and preference-seeking could foster ownership and self-responsibility, supporting sustained engagement with treatment, which DOT may contradict.

Facilitators and barriers for tuberculosis preventive treatment among patients with latent tuberculosis infection: a qualitative study

“…Patient who trusts their HCP with good skills and ethics takes TPT while the misconception of doctors using drugs as the test is a barrier to TPT [27]. This differs from the norm in many developed countries where patients are involved in their health and treatment choices [29]. Reasons for this could be due to the lack of LTBI knowledge among patients and HCPs which is crucial in the treatment decision-making process [30].…”

Person‐centred care and short oral treatment for rifampicin‐resistant tuberculosis improve retention in care in Kandahar, Afghanistan

“…However, the power balance between health care workers (HCWs) and patients remains unclear. Studies from South Africa and Uzbekistan report that the concept of shared decision-making was unfamiliar to most people with RR-TB and many chose to defer treatment choice to the HCW, perceived as being knowledgeable and experienced, thus best placed to take such decisions [15]. In Kandahar, levels of patient participation in decisionmaking and treatment ownership, and how this affected the patient's motivation to adhere to treatment, needs to be explored through further qualitative studies.…”

“…Their composition followed the WHO recommendations [3] and differed considering age, fluoroquinolone susceptibility and pregnancy (Figure 1). Those not eligible for the trial (previous exposure to second-line antituberculosis medications, contraindications for any of the medications in the regimen, severe clinical condition that requires individualised approach) or not willing to provide consent for participation, were treated by individualised regimen based on WHO guidelines [15].…”

Recent advances in tuberculosis: A comprehensive review of emerging trends in pathogenesis, diagnostics, treatment, and prevention

“…Patient-centered care: Successful TB treatment outcomes rely on patient education, shared decisionmaking and overcoming obstacles to care. 32 Its enduring dedication to patient care is always on the lookout for practical solutions A: The TB treatment is constantly evolving. In order to continue the progress made in treatment, research and innovative work is necessary not only within individual healthcare systems but across them along with their public health institutions.…”